Sequoia China Leads $50M Series C Round In Antibody Discovery Firm Adagene

For Digital Subscribers Only

Sequoia China has led a US$50 million series C round in Suzhou-based antibody discovery and development firm Adagene Inc.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY